Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

UK Genomics Medicine Start-up Congenica Ltd Wins Genomics England Competition

Published: Tuesday, May 06, 2014
Last Updated: Tuesday, May 06, 2014
Bookmark and Share
Funding to be used by Congenica to further develop it’s SAPIENTIA™ platform.

Cambridge based Congenica Ltd has announced that it has been one of several Small Business Research Initiative competition awards funded by the UK Department of Health and managed by Genomics England.

This funding will be used by Congenica to further develop it’s SAPIENTIA™ platform that provides a novel, modular, and scalable data analytics pipeline for the annotation and clinical interpretation of genomic sequence data in both human genetic disease testing and research environments.

Tom Weaver, Congenica’s CEO, said: “Winning this competition is very important for a small start-up company like ours as it demonstrates our potential and a measure of how critical the analysis tools we are developing will be for supporting national scale screening projects, including Genomics England’s fantastic ambition to sequence 100,000 genomes in a clinical context.”

Data analytics that allow the intelligent interpretation of genome sequence and clinical phenotypes in a safe, affordable and scalable manner is the next challenge as genomic technology transforms the way doctors diagnose disease and decide on the best treatment choices.

Congenica’s first product is built upon world leading technology developed by the Wellcome Trust Sanger Institute that has delivered many thousands of genomes and it is the company’s vision to apply this technology in the clinic in order to make a real difference in the treatment and outcome of patients with genetic disease.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Congenica’s Diagnostic Technology Validated by Genomics England
Company selected as one of the winners of a whole genome annotation assessment.
Thursday, October 16, 2014
Congenica and Northern Health Science Alliance Announces Partnership
Partnership set to accelerate development of diagnostic tools and improve outcomes for patients.
Saturday, May 10, 2014
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Discovered Through ‘Big Data’ Analysis
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming.
Deciphering Inactive X Chromosomes
Untangling the Barr body of inactive X chromosomes valuable for understanding chromosome structure and gene expression.
Micro Disease-Detecting Senor Created
Researchers at McMaster University have created a microscopic disease-detecting sensor that can turn on to detect trace amounts of substances.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Understanding Treatment Resistant Melanoma
Researchers have determined how advanced melanoma becomes resistant; a development toward developing treatments.
Investigating ‘Black Box’ of Human Genetics
Investigations into inactive X chromosomes have shown unusual DNA repeat elements are essential for maintaining 3D structure.
Liquid Biopsies: DNA Size Matters
Study finds circulating tumour DNA can be distinguished from healthy DNA through fragment size identification.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!